Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Product Categories
(Total 7 Products for Pf 02341066)
CAS NO.877399-52-5 Crizotinib 99.5%
High Purity Best Price CAS NO. 877399-52-5 Crizotinib Powder Crizotinib is a targeted therapy drug for non-small cell lung cancer developed by Pfizer Pharmaceuticals of the United States. The brand name is secure. Secure is a cutting-edge and epoch-making drug in the field of lung cancer targeted therapy. It was...
99% Crizotinib CAS 877399-52-5
Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in...
Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in...
CAS NO.877399-52-5 Crizotinib 99.5%
High Purity Best Price CAS NO. 877399-52-5 Crizotinib Powder Crizotinib is a targeted therapy drug for non-small cell lung cancer developed by Pfizer Pharmaceuticals of the United States. The brand name is secure. Secure is a cutting-edge and epoch-making drug in the field of lung cancer targeted therapy. It was...
Pharmaceutical Crizotinib 877399-52-5
Product Description Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its...
Pharmaceutical Crizotinib 877399-52-5 99%
Product Description Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its...
CAS:877399-52-5 Crizotinib,PF-02341066 99%
ITEMS SPECIFICATION RESULTS
Categories
High Quality Products
Send Us a Message
We didn't put all products on website. If you can't find the product you're looking for, please contact us for more information.
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.